SEC Form 4 · accession 0001638599-17-000668

SELECTA BIOSCIENCES INC · SELB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Jun 29, 2017

Accepted (ET)

Jun 30, 2017 · 4:33 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001453687

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jun 29, 2017	M	3,846	$0.47	A	3,882	D
Common Stock^F2	Jun 29, 2017	M	5,770	$0.63	A	9,652	D
Common Stock^F1,F2,F3	Jun 29, 2017	S	9,616	$20.0002	D	36	D
Common Stock^F4	Jun 29, 2017	S	36	$20.00	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1,F5	$0.47	Jun 29, 2017	M	3,846	D	—	Sep 19, 2019	Common Stock	3,846	0	D
Employee Stock Option (right to buy)^F2,F5	$0.63	Jun 29, 2017	M	5,770	D	—	Sep 6, 2020	Common Stock	5,770	9,614	D

F1The transactions reported for the 3,846 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
F2The transactions reported for the 5,770 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.01, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the set forth herein.
F4The 36 shares sold were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2016.
F5All shares underlying this option are fully vested.